Protocolo de estudio y tratamiento de la trombocitopenia inmune primaria: PTI-2018

Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial

Emilio Monteagudo; Itziar Astigarraga; Áurea Cervera; María Angeles Dasí; Ana Sastre; Rubén Berrueco; José Luis Dapena

2019

Scholarcy highlights

  • Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial
  • The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of primary immune thrombocytopenia in children, based on current guidelines, bibliographic review, clinical assays, and member consensus
  • The main objective is to reduce clinical variability in diagnostic and therapeutic procedures, in order to obtain best clinical results with minimal adverse events and good quality of life

Need more features? Save interactive summary cards to your Scholarcy Library.